Amgen Inc. (TSX:AMGN)

Amgen Revenue

Amgen had revenue of $10.05B USD in the quarter ending June 30, 2026, with 9.53% growth. This brings the company's total for the last twelve months to $38.10B, up 9.10% year-over-year. In the year 2025, Amgen had annual revenue of $36.75B with 9.95% growth.

• Revenue (ttm): $38.10B
• Revenue Growth: +9.10%
• P/S Ratio: 6.23
• Revenue / Employee: $1.21M
• Employees: 31,500
• Market Cap: 337.00B CAD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Segment

By Segment

Chart

• Other Products 7.26B 19.8%
• Prolia 4.41B 12.0%
• Repatha 3.02B 8.2%
• Otezla 2.27B 6.2%
• ENBREL 2.23B 6.1%
• EVENITY 2.10B 5.7%
• XGEVA 2.08B 5.7%
• Other 13.38B 36.4%

By Geography

Chart

• U.S. 26.42B 71.9%
• Rest of World (ROW) 10.33B 28.1%

Fiscal year ended Dec 31, 2025 See the full Amgen breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	36.75B	3.33B	9.95%
Dec 31, 2024	33.42B	5.23B	18.57%
Dec 31, 2023	28.19B	1.87B	7.09%
Dec 31, 2022	26.32B	344.00M	1.32%
Dec 31, 2021	25.98B	555.00M	2.18%
Dec 31, 2020	25.42B	2.06B	8.83%
Dec 31, 2019	23.36B	-385.00M	-1.62%
Dec 31, 2018	23.75B	898.00M	3.93%
Dec 31, 2017	22.85B	-142.00M	-0.62%
Dec 31, 2016	22.99B	1.33B	6.14%
Dec 31, 2015	21.66B	1.60B	7.97%
Dec 31, 2014	20.06B	1.39B	7.43%
Dec 31, 2013	18.68B	1.41B	8.17%
Dec 31, 2012	17.27B	1.68B	10.80%
Dec 31, 2011	15.58B	529.00M	3.51%
Dec 31, 2010	15.05B	411.00M	2.81%
Dec 31, 2009	14.64B	-361.00M	-2.41%
Dec 31, 2008	15.00B	232.00M	1.57%
Dec 31, 2007	14.77B	503.00M	3.53%
Dec 31, 2006	14.27B	1.84B	14.79%
Dec 31, 2005	12.43B	-	-

Data Source: Fiscal.ai Last updated: Jun 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error